These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 2675739)
1. [Anti-cytoskeleton antibodies and their value in cutaneous histopathology]. Kanitakis J Ann Dermatol Venereol; 1989; 116(5):431-6. PubMed ID: 2675739 [No Abstract] [Full Text] [Related]
2. Immunohistochemistry in dermatopathology: a review of the most commonly used antibodies (part I). Fuertes L; Santonja C; Kutzner H; Requena L Actas Dermosifiliogr; 2013 Mar; 104(2):99-127. PubMed ID: 23062957 [TBL] [Abstract][Full Text] [Related]
3. Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies. Moch C; Moysan A; Lubin R; de la Salmonière P; Soufir N; Galisson F; Vilmer C; Venutolo E; Le Pelletier F; Janin A; Basset-Séguin N Br J Cancer; 2001 Dec; 85(12):1883-6. PubMed ID: 11747330 [TBL] [Abstract][Full Text] [Related]
8. [Applications of electron microscopy in dermatology]. Sterniczky B; Födinger D; Sauter B; Rappersberger K Hautarzt; 1996 Feb; 47(2):148-65 quiz 162-3. PubMed ID: 8868462 [No Abstract] [Full Text] [Related]
9. [Assessment of the significance of histological, immunohistochemical and clinical data in the diagnosis of lymphoproliferative skin diseases in conformance with a consensus by international experts]. Belousova IIe; Kazakov DV; Samtsov AV; Kempf W Arkh Patol; 2004; 66(2):11-6. PubMed ID: 15154375 [TBL] [Abstract][Full Text] [Related]
10. The incidence of skin cancer is growing rapidly. Nouri K Int J Dermatol; 2004 Aug; 43(8):622. PubMed ID: 15304193 [No Abstract] [Full Text] [Related]
11. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases. Kikuchi A; Nishikawa T Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520 [TBL] [Abstract][Full Text] [Related]
12. Microphthalmia transcription factor immunohistochemistry: a useful diagnostic marker in the diagnosis and detection of cutaneous melanoma, sentinel lymph node metastases, and extracutaneous melanocytic neoplasms. O'Reilly FM; Brat DJ; McAlpine BE; Grossniklaus HE; Folpe AL; Arbiser JL J Am Acad Dermatol; 2001 Sep; 45(3):414-9. PubMed ID: 11511840 [TBL] [Abstract][Full Text] [Related]
13. Recent advances in dermatopathology. Patterson JW Va Med; 1988 Dec; 115(12):572-7. PubMed ID: 3239193 [No Abstract] [Full Text] [Related]
15. [Contribution of immunohistochemistry to diagnosis of cutaneous tumors]. Kanitakis J; Faure M; Claudy A Ann Dermatol Venereol; 1998 May; 125(5):354-69. PubMed ID: 9747290 [No Abstract] [Full Text] [Related]
16. [Value of Michel's medium in cutaneous histopathology]. Heid E; Couppié P Ann Dermatol Venereol; 1993; 120(6-7):481-3. PubMed ID: 8279798 [No Abstract] [Full Text] [Related]
17. The role of immunohistochemistry in the diagnosis of cutaneous lymphoma. Smoller BR Adv Dermatol; 1997; 13():207-34. PubMed ID: 9551145 [No Abstract] [Full Text] [Related]
18. [What will the future bring in cutaneous histopathology?]. Grosshans E Ann Dermatol Venereol; 1999 May; 126(5):396-8. PubMed ID: 10434100 [No Abstract] [Full Text] [Related]
19. Expression of the CD1a molecule in B- and T-lymphoproliferative skin conditions. Pigozzi B; Bordignon M; Belloni Fortina A; Michelotto G; Alaibac M Oncol Rep; 2006 Feb; 15(2):347-51. PubMed ID: 16391853 [TBL] [Abstract][Full Text] [Related]
20. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma. Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]